These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6997396)

  • 21. Loss of bullous pemphigoid antigen in peritumoral lacunas of basal cell carcinomas.
    Mérot Y; Faucher F; Didierjean L; Saurat JH
    Acta Derm Venereol; 1984; 64(3):209-13. PubMed ID: 6204481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunopathologic mechanisms in pemphigus and bullous pemphigoid.
    Jordon RE; Kawana S; Fritz KA
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):72s-78s. PubMed ID: 3891883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pemphigoid and pemphigus antigens in cultured epidermal cells.
    Diaz LA; Marcelo CL
    Br J Dermatol; 1978 Jun; 98(6):631-7. PubMed ID: 354682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical study on 70 human embryos concerning the epidermal binding of pemphigus and pemphigoid antibodies.
    Varelzidis A; Tosca A; Coumantakis E; Nicolis G; Hatzis J; Papavasiliou S; Stratigos J
    Acta Derm Venereol; 1980; 60(2):129-33. PubMed ID: 6155018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of extracellular and intracellular bullous pemphigoid antigens at the dermal-epibolic junction in organ culture of human skin.
    Ikeda S; Yaguchi H; Ogawa H
    J Invest Dermatol; 1990 Mar; 94(3):336-40. PubMed ID: 2407787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a 160-kD molecule as a component of the basement membrane zone and as a minor bullous pemphigoid antigen.
    Zhu XJ; Niimi Y; Bystryn JC
    J Invest Dermatol; 1990 Jun; 94(6):817-21. PubMed ID: 1693941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bullous pemphigoid antigen localization suggests an intracellular association with hemidesmosomes.
    Westgate GE; Weaver AC; Couchman JR
    J Invest Dermatol; 1985 Mar; 84(3):218-24. PubMed ID: 2579167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deposition of the membrane attack complex of complement in bullous pemphigoid.
    Dahl MV; Falk RJ; Carpenter R; Michael AF
    J Invest Dermatol; 1984 Feb; 82(2):132-5. PubMed ID: 6363566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 230-kD basic protein is the major bullous pemphigoid antigen.
    Mueller S; Klaus-Kovtun V; Stanley JR
    J Invest Dermatol; 1989 Jan; 92(1):33-8. PubMed ID: 2462597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneous distribution of bullous pemphigoid antigen during hair development in the mouse.
    Bard S; Micouin C; Thivolet J; Sengel P
    Arch Anat Microsc Morphol Exp; 1981; 70(2):141-8. PubMed ID: 7034649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
    Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
    J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional variation in the expression of bullous pemphigoid antigen and location of lesions in bullous pemphigoid.
    Goldberg DJ; Sabolinski M; Bystryn JC
    J Invest Dermatol; 1984 Apr; 82(4):326-8. PubMed ID: 6368699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of bullous pemphigoid, pemphigus, laminin, and anchoring fibril antigens in human fetal skin.
    Lane AT; Helm KF; Goldsmith LA
    J Invest Dermatol; 1985 Jan; 84(1):27-30. PubMed ID: 3880793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization of bullous pemphigoid antigen (BPA) in isolated human keratinocytes.
    Regnier M; Vaigot P; Michel S; Prunieras M
    J Invest Dermatol; 1985 Sep; 85(3):187-90. PubMed ID: 3897391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of specific histologic changes in guinea pig skin treated with bullous pemphigoid antibodies.
    Gammon WR; Briggaman RA
    J Invest Dermatol; 1988 Apr; 90(4):495-500. PubMed ID: 3280699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some biochemical properties of pemphigoid antigen bound to the surface of dissociated epidermal basal cells.
    Grekin PM; Levy GN; King AJ; Diaz LA
    J Invest Dermatol; 1981 Mar; 76(3):190-2. PubMed ID: 7017011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus-transformed lymphocytes from patients with bullous diseases produce autoantibodies to cytokeratins.
    Viac J; Paire J; Desgranges C; Iwatsuki K; Thivolet J
    Clin Immunol Immunopathol; 1986 May; 39(2):277-84. PubMed ID: 2421952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies].
    Courville P; Kupfer I; Gilbert D; Thomine E; Metayer J; Joly P
    Ann Pathol; 2000 Dec; 20(6):564-9. PubMed ID: 11148352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin.
    Gammon WR; Lewis DM; Carlo JR; Sams WM; Wheeler CE
    J Invest Dermatol; 1980 Oct; 75(4):334-9. PubMed ID: 7000926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of bullous pemphigoid antibodies to basal cells.
    Nishikawa T; Kurihara S; Harada T; Hatano H
    J Invest Dermatol; 1980 Jun; 74(6):389-91. PubMed ID: 6991608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.